company focused on marketing, sales and logistics of chemicals, polymers, and additives.
Please wait, loading...
Please wait, loading...
company focused on marketing, sales and logistics of chemicals, polymers, and additives.
This Financial Analysis Report gives stakeholders an accurate representation of company’s finances, including their Revenue, CAPEX, Profit and more and also provides in-depth insights into all financial information. In this solution, important financial KPIs are highlighted that demonstrates company’s overall health which are very vital for their success. This financial report is crucial for the finance heads who are looking to make informed decisions about their business.
Several issues hindered growth and profitability for this organization: Revenue consistently fell short of expectations across the organization, with no clear insight into root causes or areas of needed improvement. Information was decentralized and mostly distributed via spreadsheets, resulting in inefficient manual effort, high risk of error, inconsistent action plans by management, and low adoption. Employees only marginally understood their Revenue Cycle Management Model, causing operational and procedural errors, along with unknown pathways to success. Poor insight into the impact of rate- and code-changes was making negotiations with payers and forecasting difficult.
Although a very different industry, this company shared similar frustrations around poor visibility: Executive Leadership and Plant Managers had poor visibility into whether orders were going out on time across the company and from individual plants. Divisions and locations had developed disparate data “camps” and varying calculations for the same performance metrics, making it difficult to aggregate and compare performance, and creating inefficiencies due to operational silos. Plant managers needed better visibility into their backlogs throughout the month in order to maintain consistent production by coordinating the job queue. We started by addressing the low-hanging fruit. Initially, delivery performance, an issue to which their bottom line was particularly sensitive.
Dynamically target high-payoff intellectual capital for customized technologies. Objectively integrate emerging core competencies before process-centric communities. Dramatically evisculate holistic innovation rather than client-centric data.
Being pharmaceuticals manufacturer, the Company has to meet the quality standards and comply with regulations.